Grifols reported EUR979.78M in Cash and Equivalent for its fiscal quarter ending in December of 2024.


Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.09M 592K Dec/2024
GlaxoSmithKline GBP 3.6B 865M Jun/2025
Grifols EUR 979.78M 334.84M Dec/2024
Life Technologies USD 17.22M 6.16M Jun/2025